• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Agios Pharmaceuticals, Inc. (AGIO)

    -NasdaqGS
    119.62 Down 0.10(0.08%) Dec 19, 4:00PM EST
    |After Hours : 119.67 Up 0.05 (0.04%) Dec 19, 7:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 33,900   8,411   8,411   6,744  
    Cost of Revenue -   -   -   -  
    Gross Profit 33,900   8,411   8,411   6,744  
    Operating Expenses
    Research Development25,527  22,575  17,407  15,279  
    Selling General and Administrative5,165  4,166  3,288  3,707  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 3,208   (18,330) (12,284) (12,242)
    Income from Continuing Operations
    Total Other Income/Expenses Net48  34  36  29  
    Earnings Before Interest And Taxes3,256  (18,296)(12,248)(12,213)
    Interest Expense -   -   -   -  
    Income Before Tax3,256  (18,296)(12,248)(12,213)
    Income Tax Expense(448) -   -  169  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops3,704  (18,296)(12,248)(12,382)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 3,704   (18,296) (12,248) (12,382)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 3,704   (18,296) (12,248) (12,382)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.